A mechanistic model of lecithin:cholesterol acyltransferase activity exploits discoidal HDL composition and structure.

Lecithin:cholesterol acyltransferase (LCAT) activity towards discoidal HDL with apoA-I was analyzed in conjunction with re-evaluation of conformational stability of apoA-I (Sparks et al., 1993). The reaction at water-lipid interface involves the formation of acyl-enzyme and cholesterol (Chol) as a nucleophilic agent can compete with water at deacylation step. Raw data on apparent kinetic parameters for LCAT activity toward discoidal HDL with fixed (Sparks et al., 1995) or varying (Sparks et al., 1998) palmitoyloleoylphosphatidylcholine (POPC) content fit the kinetic equation derived. At the increase of Chol content in complexes with fixed POPC, interfacial dissociation constant K(d)(∗) for LCAT penetration decreased and interfacial Michaelis constant K(m)(∗) did not change. Also, differences in stability and unfolding cooperativity between two domains in apoA-I molecule increased. At the increase of surface area of the complexes with varying POPC, K(d)(∗) increased, while K(m)(∗) decreased. For both lipidation states the rate constant of acyl-LCAT formation did not vary and any changes in K(m)(∗) are postulated to originate from the change(s) in association/dissociation rate constants of enzyme-substrate complex. Then, at the increase of POPC, the LCAT-POPC complex becomes more stable. ApoA-I seems to "activate" substrate by increasing the exposure of POPC ester bond to active center of LCAT.

A proposed architecture for lecithin cholesterol acyl transferase (LCAT): identification of the catalytic triad and molecular modeling.

The enzyme cholesterol lecithin acyl transferase (LCAT) shares the Ser/Asp-Glu/His triad with lipases, esterases and proteases, but the low level of sequence homology between LCAT and these enzymes did not allow for the LCAT fold to be identified yet. We, therefore, relied upon structural homology calculations using threading methods based on alignment of the sequence against a library of solved three-dimensional protein structures, for prediction of the LCAT fold. We propose that LCAT, like lipases, belongs to the alpha/beta hydrolase fold family, and that the central domain of LCAT consists of seven conserved parallel beta-strands connected by four alpha-helices and separated by loops. We used the conserved features of this protein fold for the prediction of functional domains in LCAT, and carried out site-directed mutagenesis for the localization of the active site residues. The wild-type enzyme and mutants were expressed in Cos-1 cells. LCAT mass was measured by ELISA, and enzymatic activity was measured on recombinant HDL, on LDL and on a monomeric substrate. We identified D345 and H377 as the catalytic residues of LCAT, together with F103 and L182 as the oxyanion hole residues. In analogy with lipases, we further propose that a potential "lid" domain at residues 50-74 of LCAT might be involved in the enzyme-substrate interaction. Molecular modeling of human LCAT was carried out using human pancreatic and Candida antarctica lipases as templates. The three-dimensional model proposed here is compatible with the position of natural mutants for either LCAT deficiency or Fish-eye disease. It enables moreover prediction of the LCAT domains involved in the interaction with the phospholipid and cholesterol substrates.